US Patent 7771930 Cancer
Patent 7771930 was granted and assigned to Cancer Research Technology Limited on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+200 characters)
Article
Patent abstract
The invention provides methods of diagnosis, prognosis and treatment of cancer related to the OBCAM and NTM genes. The methods are particularly suited to ovarian and colorectal cancers.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Grant Clark Sellar0
Hani Gabra0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07771930 Cancer US Patent 7771930 Cancer
Infobox
Patent Number
077719300
Patent Number
77719300
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077719300
Date of Patent
August 10, 2010
0Patent Application Number
104821990
Date Filed
June 20, 2002
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07771930 Cancer
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07771930
Date of patent
August 10, 2010
Patent application number
10482199
Date Filed
June 20, 2002
Patent primary examiner
Find more entities like US Patent 7771930 Cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
